Return to Article Details
RISK STRATIFICATION AND MINIMAL RESIDUAL DISEASE AFTER INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA
Download
Download PDF